George Rodrigues, MD, PhD, FASTRO
Dr. George Rodrigues is a Clinician Scientist and Radiation Oncologist at the London Health Sciences Centre Research Institute and London Health Sciences Centre. He has consulted on and provides radiation treatment for patients with genitourinary and thoracic cancers as well as brain metastases since 2001 after his graduation from the University of Toronto Radiation Oncology Residency Program. He is a former award-winning Residency Program Director and currently sits on various boards and committees for ASTRO, CARO, and NRG Oncology. He is the current president of the Canadian Association of Radiation Oncology. He is academically appointed to the departments of radiation oncology and has supervised several doctoral, master’s, and post-graduate trainees. He has attained both a M.Sc. degree in Clinical Epidemiology and Biostatistics (Thesis - Health Related Quality of Life) and a Ph.D. degree in Medicine (Thesis - Brain Metastases). His current research interests include: clinical trial design, evidence synthesis, “big-data” statistical analysis, and multisite arc-based hypofractionated radiotherapy and guideline development.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none